Tous les communiqués | WebDisclosure

Switch to English

11118	Sociétés
244805	Mots-clés
172884	Articles
131993	Communiqués

Accueil
Tous les communiqués

COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 10:05, il y a 9 mois 17 jours

UTI Investments Partners with FTSE Russell to Transition its Sovereign Bond ETF Benchmark
UTI Investments partners with FTSE Russell to transition its Sovereign Bond ETF benchmark from Nifty India Government FAR Index to FTSE Indian Government Bond FAR Index, reflecting global interest in India's fixed income markets

FTSE Russell UTI Investments Sovereign Bond ETF FTSE Indian Government Bond FAR Index India Government Bonds
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 09:30, il y a 9 mois 17 jours

Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth
Topadur Pharma AG appoints Matthias Schäfer as Chief Executive Officer to lead company growth into next phase of clinical development and expansion. Dr. Reto Naef transitions to Senior Scientific Advisor

Clinical Development Chief Executive Officer Topadur Pharma AG Matthias Schäfer Scientific Advisor
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 09:30, il y a 9 mois 17 jours

Designated Person Notification
Aperam announces Designated Person Notification regarding share transactions as per Market Abuse Regulations. Aperam is a global stainless steel player committed to the circular economy

Share Transactions Market Abuse Regulations Aperam Circular Economy Designated Person Notification
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 09:30, il y a 9 mois 17 jours

Designated Person Notification
Aperam S.A. announces Designated Person Notification of share transactions in accordance with Market Abuse Regulations. Global stainless steel player committed to circular economy

Market Abuse Regulations Aperam Circular Economy Stainless Steel Designated Person Notification
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 09:21, il y a 9 mois 17 jours

Heidelberg Pharma: Letter from the CEO
Heidelberg Pharma CEO addresses delays in milestone payment, emphasizing continued development of TLX250-CDx and promising phase I study results for pamlectabart tismanitin (HDP-101). Financial challenges are being addressed proactively

CEO Heidelberg Pharma Milestone Payment TLX250-CDx Pamlectabart Tismanitin
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 09:05, il y a 9 mois 17 jours

Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand

Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 09:05, il y a 9 mois 17 jours

Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies
BioNxt Solutions Inc. announces breakthrough in drug delivery for dysphagia, securing first national-level patent for thin-film platform, targeting autoimmune markets with bioequivalent cladribine treatment

BioNxt Solutions Inc. Drug Delivery Dysphagia Thin-film Platform Autoimmune Markets
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 09:00, il y a 9 mois 17 jours

Financial Conduct Authority:
Financial Conduct Authority admits multiple securities to the Official List on 17-Dec-2025, including shares, ETFs, and debt-like securities from various issuers

Securities Financial Conduct Authority Official List Issuers Debt-like Securities
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 09:00, il y a 9 mois 17 jours

Removal- Diversity Funding No. 1 Limited
Financial Conduct Authority removes Diversity Funding No. 1 Limited securities from the Official List on 17/12/2025, 08:00 GMT. Debt-like securities delisted

Securities Financial Conduct Authority Official List Debt-like Securities Diversity Funding No. 1 Limited
COMMUNIQUÉ DE PRESSE

publié le 17/12/2025 à 08:30, il y a 9 mois 17 jours

Neo Energy Metals plc - Restoration
The Financial Conduct Authority restores Neo Energy Metals plc to the Official List, effective from 17/12/2025, 07:30 GMT/BST

Financial Conduct Authority Equity Shares Restoration Official List Neo Energy Metals Plc

Les Echos

Publié le 02/10/2026 à 17:45, il y a 1 jour 10 heures

Information concerning the total number of voting rights and shares 2026 09 30
Publié le 02/10/2026 à 17:45, il y a 1 jour 10 heures

Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Publié le 02/10/2026 à 17:35, il y a 1 jour 10 heures

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Publié le 02/10/2026 à 17:30, il y a 1 jour 10 heures

Aéroports de Paris SA - 2027 Financial Calendar
Publié le 02/10/2026 à 17:30, il y a 1 jour 10 heures

Aéroports de Paris SA - Calendrier financier 2027

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 03/10/2026 à 02:35, il y a 1 jour 1 heure

Jaguar Health Announces a Special Stock Dividend
Publié le 02/10/2026 à 17:45, il y a 1 jour 10 heures

Sparton Provides Status Update
Publié le 02/10/2026 à 13:50, il y a 1 jour 14 heures

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Publié le 02/10/2026 à 13:00, il y a 1 jour 15 heures

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Publié le 02/10/2026 à 13:00, il y a 1 jour 15 heures

Alaska Energy Metals Appoints Independent Director, Thomas Benson

Voir tout ACCESSWIRE

EQS Group

Publié le 03/10/2026 à 15:45, il y a 12 heures 39 minutes

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Publié le 02/10/2026 à 23:55, il y a 1 jour 4 heures

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Publié le 02/10/2026 à 20:23, il y a 1 jour 8 heures

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Publié le 02/10/2026 à 19:46, il y a 1 jour 8 heures

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Publié le 02/10/2026 à 19:00, il y a 1 jour 9 heures

INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF